PFAPA syndrome is the most common periodic fever condition in children, marked by clockwork-like episodes of high fever accompanied by mouth sores, sore throat, and swollen neck lymph nodes.1PubMed Central. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: A review The name itself is an acronym for its hallmark features: Periodic Fever, Aphthous Stomatitis (mouth ulcers), Pharyngitis (throat inflammation), and Adenitis (swollen glands). Most cases appear before age five, and children are completely well between flares, which is one of the syndrome’s most distinctive and puzzling characteristics.2PubMed Central. Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome in Children-From Pathogenesis to Treatment Strategies: A Comprehensive Review
What the Episodes Look Like
A PFAPA flare typically lasts three to seven days and arrives with striking regularity, often every three to six weeks. Parents frequently describe being able to predict the next episode on a calendar. The fever itself is usually high, often above 39°C (about 102°F), and it starts abruptly. Alongside the fever, children may have painful shallow ulcers inside the mouth, a visibly red throat, and tender, enlarged lymph nodes on one or both sides of the neck. Not every feature shows up in every episode: some children get all four, while others may only have fever plus pharyngitis or fever plus mouth sores.2PubMed Central. Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome in Children-From Pathogenesis to Treatment Strategies: A Comprehensive Review
Between flares, children grow normally, hit developmental milestones on schedule, and have no lingering symptoms. This is a key distinction from many other childhood inflammatory conditions, where ongoing low-grade inflammation or growth problems persist even between acute episodes. Standard fever reducers like ibuprofen bring the temperature down temporarily during a flare, but the episode itself runs its course over several days regardless.
Some children also experience less commonly discussed symptoms during flares, including headache, abdominal pain, joint pain, and fatigue. These are not part of the classic acronym but show up often enough to be worth mentioning. When abdominal pain, diarrhea, vomiting, or skin rashes are prominent, clinicians start thinking harder about whether the child might have a different periodic fever syndrome altogether, a distinction covered below.
What Drives the Immune Flares
PFAPA is not caused by an infection, even though each episode looks a lot like one. The underlying problem appears to be a misfiring of the innate immune system. During flares, genes tied to complement activation and the inflammatory molecule IL-1β are switched on at high levels, while markers of normal T-cell activity are actually suppressed. The result is a burst of inflammation centered on the throat and mouth that mimics a bacterial infection but resolves on its own without antibiotics.3PubMed Central. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade
Research on blood cells during flares has confirmed that monocytes, a type of white blood cell, produce far more IL-1β during a febrile episode than in the quiet period between attacks. In one study, stimulated monocytes released roughly three times as much IL-1β during fever compared to the interval period.4PubMed. Periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome is linked to dysregulated monocyte IL-1β production This overproduction of IL-1β seems central to the whole cascade: it drives the fever, the throat inflammation, and the surge in other inflammatory signals that accompany each flare.
The tonsils themselves appear to be a key battleground. Even when children with PFAPA feel perfectly fine between episodes, their tonsils show persistent low-level inflammation, with elevated numbers of certain immune cells and ongoing activation of inflammatory signaling pathways. The microbial community living on PFAPA tonsils also differs from that of healthy children.5PubMed Central. Immune Dysregulation in the Tonsillar Microenvironment of Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA) Syndrome One study comparing the tonsillar bacteria of PFAPA patients and controls found significantly different microbial profiles, with some unusual organisms more common in PFAPA and typical streptococci less abundant.6PubMed. Tonsillar microbiota in children with PFAPA (periodic fever, aphthous stomatitis, pharyngitis, and adenitis) syndrome This persistent tonsillar inflammation likely explains why removing the tonsils often resolves the syndrome entirely.
Genetics and the Emerging Picture
For years, PFAPA was assumed to have no genetic component, partly because it did not follow the inheritance patterns seen in conditions like Familial Mediterranean Fever. That assumption has eroded. Genome-wide studies have identified shared genetic susceptibility loci linking PFAPA to Behçet’s disease and recurrent aphthous ulcers, suggesting a common genetic thread in how the immune system handles mucosal inflammation.7PubMed Central. What is PFAPA syndrome? Genetic clues about the pathogenesis
A large genetic analysis found that a variant near the IL12A gene roughly doubles the risk of PFAPA, and people carrying this variant produce higher levels of IL-12 from their monocytes when stimulated. Additional risk variants near genes involved in T-cell activity and anti-inflammatory signaling were also identified.8PubMed Central. Common genetic susceptibility loci link PFAPA syndrome, Behçet’s disease, and recurrent aphthous stomatitis The current view is that PFAPA is a complex genetic disorder: no single gene causes it, but several common variants together tilt the immune system toward the kind of mucosal overreaction that defines the syndrome. Environmental triggers then set off individual flares against this genetic backdrop.
What Triggers Individual Episodes
The regularity of PFAPA flares has puzzled researchers for decades, and the triggers for any given episode are often unclear. A study evaluating attack triggers across a large group of PFAPA patients found that the most commonly reported trigger was infection or vaccination, identified in about 16% of episodes, followed by physical or emotional stress in about 9% and food-related triggers in about 7%.9Trends in Pediatrics. Evaluation of the clinical characteristics of patients with PFAPA syndrome according to attack triggers In the majority of flares, no specific trigger could be identified at all. Parents often notice seasonal clustering, with more episodes during the school year than summer, but this has not been firmly established in controlled studies.
The fact that most flares occur without a clear external trigger fits with the idea that the tonsils are simmering with low-grade inflammation between episodes and periodically reach a tipping point. In this model, the immune system essentially reboots itself every few weeks, cycling through a buildup and release of inflammation that follows its own internal clock rather than responding to any single external event.
Getting a Diagnosis
There is no blood test, imaging scan, or genetic marker that can confirm PFAPA. The diagnosis is clinical, meaning it rests on a recognizable pattern of symptoms, a history of clockwork fevers, and the exclusion of other conditions. The most widely used criteria are the modified Marshall criteria, first proposed in the 1980s. Under these criteria, a child needs recurrent fevers starting before age five, at least one of the three accompanying features (mouth sores, pharyngitis, or adenitis), normal growth and development between episodes, and exclusion of cyclic neutropenia and other periodic fever syndromes.
Efforts to tighten these criteria have had mixed results. A newer set of classification criteria developed through expert consensus was notably more restrictive: when applied to a cohort of known PFAPA patients, only about half met the stricter criteria, compared to 86% who met the modified Marshall criteria.10PubMed Central. Towards a new set of classification criteria for PFAPA syndrome When tested in a separate validation study, the new criteria had high specificity (about 91%) but low sensitivity (about 61%), meaning they were good at ruling out conditions that mimic PFAPA but missed a substantial number of children who genuinely had it.11Annals of the Rheumatic Diseases. EVALUATION OF THE NEW CLASSIFICATION CRITERIA FOR PFAPA SYNDROME Removing the skin-rash exclusion criterion from the new set improved sensitivity to about 81% with only a small drop in specificity, but no universally accepted revision has been adopted.
The practical upshot for families is that getting a PFAPA diagnosis often takes time and multiple visits. Blood tests during a flare typically show elevated inflammatory markers (like C-reactive protein and erythrocyte sedimentation rate) and sometimes shifts in white blood cell counts, but these findings are nonspecific. They help confirm that something inflammatory is happening but do not point to PFAPA specifically.
Ruling Out Look-Alike Conditions
The biggest diagnostic challenge is distinguishing PFAPA from monogenic periodic fever syndromes, conditions caused by mutations in a single gene. In a study of nearly 400 children who met PFAPA criteria, genetic testing revealed that about 11% actually carried disease-causing mutations for conditions like mevalonate kinase deficiency, tumor necrosis factor receptor-associated periodic syndrome, or Familial Mediterranean Fever.12Pediatrics. Differentiating PFAPA Syndrome From Monogenic Periodic Fevers Children with these genetic conditions were more likely to have abdominal pain, diarrhea, vomiting, skin rashes, and joint pain during flares. Children with true PFAPA were more likely to have exudative pharyngitis, where the throat not only turns red but develops visible white patches.
Ethnicity and family history also provide clues. Familial Mediterranean Fever is far more common in children of Mediterranean, Middle Eastern, and Armenian descent. The regularity of flares can also help: PFAPA flares tend to be strikingly regular, while the monogenic conditions often have more variable intervals. Still, these are guidelines rather than hard lines, and genetic testing is increasingly used to settle borderline cases.
Treating Flares With Corticosteroids
A single dose of a corticosteroid, typically prednisone or prednisolone, given at the onset of fever is the standard acute treatment for a PFAPA flare. It works remarkably well: about 95% of patients respond with rapid resolution of fever, usually within hours.13PubMed. Corticosteroid use in PFAPA syndrome: clinical practice data from the JIR-CliPS Survey Study and a comprehensive literature review This dramatic response to a single steroid dose is itself considered a supporting diagnostic feature; most infections and other causes of recurrent fever do not resolve so cleanly after one dose of prednisone.
There is a well-known trade-off, however. While steroids shut down the current flare, roughly a third of patients find that the interval between episodes shortens after regular steroid use.14PubMed Central. PFAPA syndrome: a review on treatment and outcome Instead of flares every four to six weeks, the gap may shrink to two or three weeks. This does not happen to every child, and for many families the relief of cutting a five-day fever down to a few hours is worth the risk of slightly more frequent episodes. But for families already dealing with flares every few weeks, the prospect of even shorter intervals can push the conversation toward tonsillectomy.
Tonsillectomy as a Definitive Treatment
Removing the tonsils is the closest thing to a cure for PFAPA. A recent meta-analysis of randomized and controlled studies found that children who underwent tonsillectomy had dramatically higher rates of complete symptom resolution compared to those managed without surgery.15PubMed Central. The efficacy of tonsillectomy in the management of PFAPA syndrome: a systematic review and meta-analysis Another pooled analysis estimated a 72% lower risk of persistent symptoms in the surgical group.16PubMed Central. Surgical management for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome: a systematic review and meta-analysis In a long-term study tracking outcomes after surgery, about 83% of patients achieved full recovery, with another 10% showing moderate improvement. Only about 4% saw no improvement at all.17PubMed. Long-term efficacy of tonsillectomy/adenotonsillectomy in patients with periodic fever aphthous stomatitis pharyngitis adenitis syndrome with special emphasis on co-existence of familial Mediterranean fever
These numbers make tonsillectomy look compelling, and for many families it is. The decision, though, involves weighing a surgical procedure with its own risks (pain, bleeding, and general anesthesia in a young child) against a condition that, while disruptive, is self-limited and causes no long-term harm. Most pediatric rheumatologists and otolaryngologists consider tonsillectomy when flares are very frequent, when corticosteroid use has shortened the interval between episodes, or when the family’s quality of life has deteriorated to the point where continued watchful waiting feels untenable. There is no strict threshold, and the timing is individualized.
The finding that PFAPA tonsils harbor persistent inflammation even between episodes helps explain why surgery works so well. Removing the site of smoldering immune activation appears to break the cycle at its source.
Preventive Medications and Refractory Cases
For families who want to reduce flare frequency without surgery, a few medications have been tried with varying degrees of evidence. Colchicine, a drug better known for treating gout and Familial Mediterranean Fever, has been studied as a preventive option in PFAPA. A systematic review of its use in children found that a short randomized comparison showed similar three-month efficacy to cimetidine, a histamine receptor blocker that has been used off-label for PFAPA for decades.18PubMed. Colchicine prophylaxis in pediatric PFAPA: a systematic review Neither drug has the kind of large trial data that corticosteroids and tonsillectomy have, and their use remains somewhat empirical.
For children who do not respond to steroids, colchicine, or cimetidine and whose families prefer to avoid surgery, IL-1 blockade with anakinra (a recombinant IL-1 receptor antagonist) has been used in small numbers. Case reports describe anakinra aborting PFAPA attacks in children, though experience is limited.19PubMed. IL-1β blockade in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: case-based review This approach is generally reserved for genuinely refractory cases and is not a first-line option.
The Antibiotic Problem
Because PFAPA flares look so much like bacterial throat infections, many children receive repeated courses of antibiotics before the diagnosis is made. A population-level study found that children with PFAPA received antibiotics at roughly three and a half times the rate of the general pediatric population in the years before diagnosis, with the youngest children (under age five) being hit hardest.20PubMed. Antibiotic prescriptions to children with periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis After diagnosis, the average number of antibiotic prescriptions dropped by about 62%, from roughly two courses per year to less than one. This is a significant reduction that underscores how much unnecessary antibiotic use PFAPA generates before it is recognized.
The pattern makes sense when you consider the clinical picture. A child shows up with a high fever and a red throat, maybe with exudates. A rapid strep test may be negative, but the presentation is concerning enough that antibiotics are prescribed empirically. The fever eventually resolves on its own (as PFAPA flares always do), and the antibiotic gets the credit. A few weeks later the same thing happens. It often takes several cycles before someone realizes the fevers are too regular and too predictable to be random infections. Raising awareness of PFAPA among primary care providers is one of the more straightforward ways to cut down on unnecessary antibiotic use in young children.
Long-Term Outlook
PFAPA is a self-limited condition. A long-term registry study following 59 patients over 12 to 21 years found that most experienced spontaneous symptom resolution with no lasting health consequences. The average duration of symptoms was about six years.21Journal of Pediatrics. Long-term follow-up of children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome This means many children outgrow the condition by late childhood or early adolescence even without tonsillectomy. No long-term organ damage, autoimmune disease, or growth problems have been linked to PFAPA in follow-up studies.
This favorable prognosis is an important part of the conversation between families and clinicians. For some families, knowing that the condition will eventually burn out on its own makes it easier to manage flares with corticosteroids and wait it out. For others, six years of monthly high fevers and missed school is simply too much disruption, and tonsillectomy offers a faster path to resolution. Neither choice is wrong.
When PFAPA Starts in Adulthood
Although PFAPA is overwhelmingly a pediatric condition, adult-onset cases exist and are increasingly recognized. Adults with PFAPA tend to present somewhat differently: they are more likely to have joint and muscle pain during flares, their episodes may last longer, and they often show only one of the classic features (mouth sores or pharyngitis, but not both) rather than the full set seen in children.22American Journal of Case Reports. Adult-Onset PFAPA Syndrome: Successful Management with Colchicine The less typical presentation, combined with the rarity of the diagnosis in adults, means that adult PFAPA is often recognized only after years of unexplained recurrent fevers.
A set of diagnostic criteria specifically for adult-onset PFAPA has been proposed, centered on fever attacks with cervical lymph node swelling, red pharyngitis, elevated inflammatory markers during episodes, and complete normalization between flares. This model showed strong diagnostic accuracy in the study population that developed it.23PubMed Central. Diagnostic Criteria for Adult-Onset Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome Whether adult PFAPA resolves spontaneously the way it usually does in children is less clear, since long-term follow-up data in adults are sparse. Corticosteroids and colchicine are the mainstays of treatment in adult patients, and tonsillectomy has been performed in some cases with reported benefit.
Impact on Daily Life and Families
The numbers tell one part of the story; the lived experience tells another. Studies assessing health-related quality of life in children with PFAPA consistently find scores well below what you would expect for healthy children. In one quality-of-life survey, health functioning scored an average of about 59 out of 100, emotional functioning about 57, and school activities about 59.24PubMed Central. Quality of Life and Psychological Functioning in Children with PFAPA Syndrome More than 60% of PFAPA patients in another study were found to have poor quality of life regarding daily activities and school attendance.25PubMed Central. Clinical characteristics and quality of life in children with PFAPA syndrome and Behçet’s disease
The dimension that scored lowest across these studies was family concern, averaging about 34 out of 100, reflecting the outsized worry that recurrent, unexplained fevers place on parents and caregivers.24PubMed Central. Quality of Life and Psychological Functioning in Children with PFAPA Syndrome The cycle of high fever, emergency department visits, courses of antibiotics that do not seem to help, missed work for parents, and missed school for children adds up. Cognitive functioning, reassuringly, scored in the moderate range, and family relationships remained relatively intact. But the emotional toll on the household is real, and it is one of the factors that often tips the balance toward pursuing tonsillectomy rather than waiting for spontaneous resolution. Acknowledging that toll, and validating it as a legitimate consideration in treatment decisions, matters as much as anything a clinician can prescribe.